Plaque REgression With Cholesterol Absorption Inhibitor or Synthesis Inhibitor Evaluated by IntraVascular UltraSound
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the difference in the effect of coronary plaque
regression (as measured by intravascular ultrasound [IVUS] imaging) between cholesterol
absorption inhibitor and cholesterol synthesis inhibitor.